Literature DB >> 6090845

Central ACTH deficit in degenerative and vascular dementia.

F Facchinetti, G Nappi, F Petraglia, E Martignoni, E Sinforiani, A R Genazzani.   

Abstract

Cerebrospinal fluid (CSF) concentrations of ACTH, beta-lipotropin (beta-LPH) and beta-endorphin (beta-EP) were measured in 15 patients affected by dementia, who underwent also a brain computerized tomography (CT), and in 13 age-matched healthy volunteers. ACTH CSF levels of patients (4.0 +/- 2.4 fmol/ml, M +/- SD) were significantly lower than in controls (9.8 +/- 5.0, P less than 0.01) the lowest values being found in Alzheimer type of dementia (ATD: 3.1 +/- 2.5) and in patients with radiological evidence of cortical atrophy (2.5 +/- 1.2), independently of the probable origin of dementia. Although beta-LPH and beta-EP levels of patients fell within normal range, they were lower in ATD than in dementia sustained on a vascular origin. There was no variation of either peptides concentration in relation to CT findings. These data indicate the ACTH impairment as typical of dementia, supporting in humans the positive role of this peptide on learning and mnesic functions. Moreover, the maintained CSF levels of both beta-LPH and beta-EP in the dementia sustained on a vascular origin, while lower values were found in ATD, could represent a differentiation between vascular and degenerative diseases of the Central Nervous System (CNS).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090845     DOI: 10.1016/0024-3205(84)90181-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Neurotransmitter markers in the cerebrospinal fluid of normal subjects. Effects of aging and other confounding factors.

Authors:  P Hartikainen; H Soininen; K J Reinikainen; J Sirviö; R Soikkeli; P J Riekkinen
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 2.  Alterations in neuropeptides in aging and disease. Pathophysiology and potential for clinical intervention.

Authors:  A Leake; I N Ferrier
Journal:  Drugs Aging       Date:  1993 Sep-Oct       Impact factor: 3.923

3.  Dissociation between CSF and plasma B-endorphin in major depressive disorders: evidence for a different regulation.

Authors:  F Facchinetti; F Petraglia; G Sances; C Garuti; P Tosca; G Nappi; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

4.  Reduced cerebrospinal fluid B-endorphin levels in Rett syndrome.

Authors:  A R Genazzani; M Zappella; A Nalin; Y Hayek; F Facchinetti
Journal:  Childs Nerv Syst       Date:  1989-04       Impact factor: 1.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.